The Kroger Company will settle its opioids lawsuit in West Virginia by paying $68 million. In this case, the retailer was accused of contributing to the oversupply of the said drugs that are legally available with a prescription.
The state of West Virginia also alleged that Kroger failed to control the sale of opioids which is a type of drug that includes heroin which is illegal. Synthetic opioids like fentanyl and pain relievers are being sold to patients with prescriptions so they can be purchased in leading drug stores.
Patrick Morrisey, the West Virginia Attorney General, confirmed on Thursday, May 3, that Kroger has settled the lawsuit. The Cincinnati, Ohio-headquartered retail chain is the last defendant in the case, which also involves other major drug stores in the United States, including Rite Aid, Walgreens, CVS, and Walmart.
“Although the hundreds of millions of dollars we secured from these companies will not bring back the lives lost from the opioid menace, our hope is that the money would provide significant help to those affected the most by this crisis in the state,” the attorney general said in a statement.
On the other hand, Kroger’s spokesman also commented that while the company “continues to believe that the allegations made against Kroger in this and other opioid lawsuits are without merit, we have decided that a settlement is the best path forward to resolve this litigation.”
At any rate, CNN Business reported that despite the hefty payment to resolve the opioid suit, the financial impact on Kroger will remain minimal. This is because it reported $4.1 billion in earnings in 2022.
Walgreens also settled with the state of West Virginia in January this year and paid $83 million, while CVS and Walmart resolved the suit with settlements of $82.5 million and $65 million, respectively, in late 2022. In the case of Rite Aid, it paid up to $30 million in August of last year.
Photo by: Mike Kalasnik/Flickr (CC BY-SA 2.0)


Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



